K. Hacène - Concepedia

Author

K. Hacène

Hôpital René Huguenin

Also Known As

K HACENE, K Hacene, K Hacène, K. HACENE, K. Hacene, K. Hacène, K. Hacéne, Kamel Hacene, Kamel Hacène, Kamel Hacène

Publications

Citations

H-Index

Concepts

All Affiliations

Hôpital René Huguenin Inserm University of Liège Institut Gustave Roussy Laboratoire National Henri Becquerel

About

K. Hacène is an author at Hôpital René Huguenin specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	30	1.7K
2	Health Sciences	5	5	358
3	Natural Sciences	1	1	27
4	Public Health	1	1	100
5	Biochemistry	1	1	27

K. Hacène

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas V Le Doussal, M. Tubiana-Hulin, Sam Friedman, Cancer	1989	372
CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER Frédérique Spyratos, K. Hacène, Jacques Rouëssé, The Lancet Cathepsin DBreast OncologyMedicinePathologyBreast Cancer	1989	319
Prognostic Factors in Localized Primary Synovial Sarcoma: A Multicenter Study of 128 Adult Patients Martine Trassard, V Le Doussal, K. Hacène, Journal of Clinical Oncology	2001	284
Anti-Colony-Stimulating Factor-1 Antibody Staining in Primary Breast Adenocarcinomas Correlates With Marked Inflammatory Cell Infiltrates and Prognosis Suzy Scholl, C. Pallud, Frédéric Beuvon, JNCI Journal of the National Cancer Institute	1994	228
Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis V Le Doussal, Jean‐Michel Coindre, Agnès Leroux, Cancer	1996	176
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors Frédéric Triebel, K. Hacène, Marie-France Pichon Cancer Letters Breast OncologyProgesterone ReceptorsPrognostic FactorHormonal ReceptorImmunology	2005	173
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas C. Bouchet, F. Spyratos, PM Martin, British Journal of Cancer UrologyBreast OncologyMedicinePrognostic ValuePathology	1994	171
Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer Ivan Bièche, M.H. Champème, F Matifas, The Lancet Breast OncologyCytogeneticsTumor HeterogeneityGeneticsPathology	1992	167
[Sem: a suitable statistical software adaptated for research in oncology]. Fabrice Kwiatkowski, M Girard, K. Hacène, PubMed	2000	156
Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast Cancer F. Spyratos, Pierre Martin, K. Hacène, JNCI Journal of the National Cancer Institute	1992	121

Page 1